Russia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...

Beata Halassy, an expert infectious disease researcher, treated her own stage 3 breast cancer by injecting the tumour with lab-grown viruse...

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In Ind...

For this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the US FDA.

Treatments, including radiation & immunotherapy, have proven to be effective in patients with metastatic solid cancers.

When combined with traditional therapy the drug for rheumatoid arthritis may effectively treat melanoma.

DCGI gave MSD permission to market Keytruda in June 2016, according to minutes of the regulator’s Subject Expert Committee on oncology and ...

The new blood tests, which take only 48 hours, are the first to identify melanoma DNA in blood.

Though the new findings are based on researches on breast cancer, researchers say the early departure of cancer cells to seed metastases ca...